Growth Metrics

Enanta Pharmaceuticals (ENTA) Net Cash Flow Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 89.97%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -13.44%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 33.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -29.82%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 32.17%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - -27.67%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -27.67%
Dec 31, 2025 69.87%
Sep 30, 2025 -40.96%
Jun 30, 2025 -18.47%
Mar 31, 2025 24.75%
Dec 31, 2024 4.02%
Sep 30, 2024 -69.74%
Jun 30, 2024 27.39%
Mar 31, 2024 2.33%
Dec 31, 2023 -12.37%
Sep 30, 2023 8.37%
Jun 30, 2023 -4.82%
Mar 31, 2023 -12.86%
Dec 31, 2022 57.86%
Sep 30, 2022 33.21%
Jun 30, 2022 7.82%
Mar 31, 2022 -56.52%
Dec 31, 2021 58.75%
Sep 30, 2021 34.91%
Jun 30, 2021 -43.68%
Mar 31, 2021 178.27%
Dec 31, 2020 -149.18%
Sep 30, 2020 -31.87%
Jun 30, 2020 102.96%
Mar 31, 2020 227.88%
Dec 31, 2019 -98.81%
Sep 30, 2019 -73.62%
Jun 30, 2019 27.92%
Mar 31, 2019 46.23%
Dec 31, 2018 -24.70%
Sep 30, 2018 124.96%
Jun 30, 2018 -60.56%
Mar 31, 2018 48.76%
Dec 31, 2017 -11.50%
Sep 30, 2017 115.71%
Jun 30, 2017 -28.28%
Mar 31, 2017 -28.12%
Dec 31, 2016 42.79%
Sep 30, 2016 6.41%
Jun 30, 2016 17.19%
Mar 31, 2016 -42.66%
Dec 31, 2015 33.83%
Sep 30, 2015 -34.01%
Jun 30, 2015 29.34%